Biotech Values

[DewDiligence]

RVNC P.S.—I will not tender my shares, since there is no advantage in doing so. There’s a slim possibility that the deal will collapse if enough shareholders do not tender, and if the deal is consummated I will end up getting the same $6.66/sh as the shareholders who tender.